Zun-Yi Zhang Selected Research

Adenocarcinoma of Lung

1/2019	Retraction Note: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
8/2018	Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
1/2017	Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
1/2016	Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zun-Yi Zhang Research Topics

Disease

11	Neoplasms (Cancer) 10/2023 - 08/2014
8	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 08/2014
4	Fibrosis (Cirrhosis) 04/2024 - 11/2021
4	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 12/2019
4	Adenocarcinoma of Lung 01/2019 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
2	Thrombosis (Thrombus) 12/2021 - 06/2018
1	Liver Failure 04/2024
1	Hypersplenism (Anemia, Splenic) 02/2023
1	Carcinogenesis 11/2022
1	Cholangiocarcinoma 01/2022
1	Disease Progression 01/2020
1	Portal Hypertension 12/2019
1	Infections 07/2017
1	Hepatitis B 07/2017
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Liver Neoplasms (Liver Cancer) 08/2015
1	Inflammation (Inflammations) 08/2014

Drug/Important Bio-Agent (IBA)

4	human MIRN623 microRNAIBA 01/2019 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2014
2	Sorafenib (BAY 43-9006)FDA Link 12/2021 - 01/2020
1	Angiogenesis InhibitorsIBA 01/2023
1	Thioredoxin Reductase 1IBA 11/2022
1	pembrolizumabIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	lenvatinibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2020
1	regorafenibIBA 01/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 07/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	MAP Kinase Kinase 4IBA 01/2016
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 08/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2015
1	Histone Deacetylase InhibitorsIBA 08/2015
1	Minocycline (Cyclops)FDA LinkGeneric 08/2014

Therapy/Procedure

8	Therapeutics 10/2023 - 01/2016
6	Hepatectomy 04/2024 - 06/2018
2	Thrombectomy 12/2021 - 06/2018
1	Neoadjuvant Therapy 10/2023
1	Surgical Instruments (Clip) 10/2023
1	Liver Transplantation 10/2023
1	Splenectomy 02/2023
1	Immunotherapy 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2021
1	Drug Therapy (Chemotherapy) 12/2021
1	Contraindications 12/2019
1	Punctures 06/2018